The stock of Ocera Therapeutics Inc (NASDAQ:OCRX) is a huge mover today! About 98,892 shares traded hands. Ocera Therapeutics Inc (NASDAQ:OCRX) has declined 17.63% since March 7, 2016 and is downtrending. It has underperformed by 25.22% the S&P500.
The move comes after 6 months positive chart setup for the $64.68M company. It was reported on Oct, 10 by Barchart.com. We have $6.07 PT which if reached, will make NASDAQ:OCRX worth $67.91 million more.
Analysts await Ocera Therapeutics Inc (NASDAQ:OCRX) to report earnings on November, 2. They expect $-0.36 EPS, down 5.88% or $0.02 from last year’s $-0.34 per share. After $-0.33 actual EPS reported by Ocera Therapeutics Inc for the previous quarter, Wall Street now forecasts 9.09% negative EPS growth.
According to Zacks Investment Research, “Ocera Therapeutics, Inc. is a biopharmaceutical company. It focused on the development and commercialization of proprietary compounds to treat acute and chronic orphan liver diseases. Ocera Therapeutics, Inc., formerly known as Tranzyme, Inc., is based in San Diego, California.”
Insitutional Activity: The institutional sentiment decreased to 0.62 in Q2 2016. Its down 0.15, from 0.77 in 2016Q1. The ratio fall, as 3 funds sold all Ocera Therapeutics Inc shares owned while 10 reduced positions. 2 funds bought stakes while 6 increased positions. They now own 6.77 million shares or 0.29% less from 6.79 million shares in 2016Q1.
Weiss Multi owns 112,995 shares or 0.02% of their US portfolio. Blackrock Inv Mgmt Ltd Com holds 0% or 2,386 shares in its portfolio. Tower Research Capital Ltd Com (Trc) has 0% invested in the company for 343 shares. Bank Of America Corporation De accumulated 0% or 137 shares. Qvt Financial L P has invested 0.1% of its portfolio in Ocera Therapeutics Inc (NASDAQ:OCRX). Pura Vida Limited Company owns 131,000 shares or 0.11% of their US portfolio. Millennium Mngmt Ltd Llc owns 516,343 shares or 0% of their US portfolio. Commercial Bank Of New York Mellon accumulated 0% or 34,136 shares. Moreover, Sabby Mngmt has 0.04% invested in Ocera Therapeutics Inc (NASDAQ:OCRX) for 424,035 shares. Deutsche Fincl Bank Ag last reported 82 shares in the company. California Public Employees Retirement reported 30,711 shares or 0% of all its holdings. Morgan Stanley has 1,317 shares for 0% of their US portfolio. Dimensional Fund Advsr Lp holds 0% of its portfolio in Ocera Therapeutics Inc (NASDAQ:OCRX) for 15,648 shares. Blackrock Fund Advisors has invested 0% of its portfolio in Ocera Therapeutics Inc (NASDAQ:OCRX). Stifel holds 0% of its portfolio in Ocera Therapeutics Inc (NASDAQ:OCRX) for 32,548 shares.
More news for Ocera Therapeutics Inc (NASDAQ:OCRX) were recently published by: Seekingalpha.com, which released: “Ocera Therapeutics: A Speculative Investment” on April 19, 2016. Globenewswire.com‘s article titled: “Ocera Therapeutics Announces Completion of Merger With Tranzyme” and published on July 15, 2013 is yet another important article.
OCRX Company Profile
Ocera Therapeutics, Inc., incorporated on January 12, 1998, is a clinical-stage biopharmaceutical company. The Firm is focused on acute and chronic orphan liver diseases. The Firm is focused on the development and commercialization of its clinical candidate, OCR-002, for the treatment of hepatic encephalopathy (HE). OCR-002 is a molecule, ornithine phenylacetate, which functions as an ammonia scavenger. The Firm relies on third-party manufacturers to produce bulk drug substance and drug products required for commercial use and for its clinical trials.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.